Delivery Order SPE2DB25D3201-SPE2DB26FNNSW
- Not listed
- The Defense Logistics Agency awarded a $8,624.13 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. Issued on September 2, 2025, with completion targeted for September 3, 2025, this firm fixed price delivery order was competitively awarded without set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This firm fixed-price delivery order, valued at $16,171.02, is not set-aside and represents a competitive award under the company's existing contract vehicles with DLA. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. This firm fixed-price delivery order, valued at $2,057.32, represents a competitive award with no set-aside designation and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,484.68 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. The contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,808.18 to AmerisourceBergen Drug Corp for Synvisc-One Syringes (6mL), a hyaluronic acid-based injectable treatment for osteoarthritis. This firm fixed-price, competitively awarded delivery order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating...
- The Defense Logistics Agency (DLA) awarded a $20.86K delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injectable treatment for osteoarthritis. This competitive delivery order, issued on September 26, 2025, with a completion date of September 29, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for osteoarthritis treatment. This firm fixed-price delivery order has a ceiling value of $3,841.20 and an ultimate completion date of September 26, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $25.2K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This firm fixed-price, non-set-aside contract is scheduled for completion by September 18, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6mL, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This competitively awarded, non-set-aside contract was finalized on August 18, 2025, with a ceiling value of $4,087.80 and a firm fixed price structure. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,608.77 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for knee osteoarthritis treatment. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a direct procurement through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA. The award carried no set-aside designation,...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNSWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,192.34 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed price, non-set-aside delivery order was awarded on October 29, 2025, with an ultimate completion date of October 30, 2025. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and serves as a critical mechanism through which AmerisourceBergen supplies a broad range of medications, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The delivery order represents a routine procurement under this expansive pharmaceutical supply agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 10/29/25 |